InVitria is a division of Ventria Bioscience, a company specializing in making recombinant medicines and other biotechnology products. InVitria is headquartered out of Aurora, Colorado, and has its manufacturing facility in Junction City, Kansas.
Ventria Bioscience's goal for InVitria is to create products that enhance cell cultures and bio-manufacturing technologies by removing any animal components from their cell-based technologies and processes. InVitria develops and manufactures animal-free bioreagents used in cell culture media, bioprocessing, biopharmaceutical formulation, vaccines, stem cells, regenerative medicine, cell therapy, scientific research, medical diagnostics.
InVitria is partnered with Sigma-Aldrich and Fisher Scientific to take advantage of their worldwide distribution network. Their combined distribution network gives InVitria access to several regional distributors in North America, Europe, Asia, and Australia.
On June 5, 2012, InVitria announced that it won a two-year SBIR grant from the National Institute of Allergy and Infectious Diseases (NIAID). InVititria is using the grant money in collaboration with the Institute for Antiviral Research at Utah State University, SoloHill Engineering, and the U.S Centers for Disease Control and Prevention's Division of Vector-Borne Diseases to develop animal-free cell culture media for the production of commercially available vaccines.